Carmine Gentile

Dr. Carmine Gentile

University of Technology Sydney
+2
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LPLiudmila Polonchuk
Liudmila Polonchuk
MCMamta Chabria
Mamta Chabria
LBLaura Badi
Laura Badi
JHJean-Christophe Hoflack
Jean-Christophe Hoflack
GFGemma Figtree
Gemma Figtree
Carmine GentileCarmine Gentile
Carmine Gentile
Three-dimensional in vitro cell systems are a promising alternative to animals to study cardiac biology and disease. We have generated three-dimensional in vitro models of the human heart (“cardiac spheroids”, CSs) by co-culturing human primary or iPSC-derived cardiomyocytes, endothelial cells and fibroblasts at ratios approximating those present in vivo. The cellular organisation, extracellular matrix and microvascular network mimic human heart tissue. These spheroids have been employed to investigate the dose-limiting cardiotoxicity of the common anti-cancer drug doxorubicin. Viability/cytotoxicity assays indicate dose-dependent cytotoxic effects, which are inhibited by the nitric oxide synthase (NOS) inhibitor L-NIO, and genetic inhibition of endothelial NOS, implicating peroxynitrous acid as a key damaging agent. These data indicate that CSs mimic important features of human heart morphology, biochemistry and pharmacology in vitro, offering a promising alternative to animals and standard cell cultures with regard to mechanistic insights and prediction of toxic effects in human heart tissue.

8 January 2010 in Expert Opinion on Biological Therapy
Verified
Journal Article
Closed access
RVRichard P Visconti
Richard P Visconti
VKVladimir Kasyanov
Vladimir Kasyanov
Carmine GentileCarmine Gentile
Carmine Gentile
JZJing Zhang
Jing Zhang
RMRoger R Markwald
Roger R Markwald
VMVladimir Mironov
Vladimir Mironov
Importance of the field: Effective vascularization of thick three-dimensional engineered tissue constructs is a problem in tissue engineering. As in native organs, a tissue-engineered intra-organ v...

22 January 2010 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
PFPaul A. Fleming
Paul A. Fleming
WAW. Scott Argraves
W. Scott Argraves
Carmine GentileCarmine Gentile
Carmine Gentile
Adrian NeaguAdrian Neagu
Adrian Neagu
GFGabor Forgacs
Gabor Forgacs
CDChristopher J. Drake
Christopher J. Drake
We evaluated the self‐assembly properties of uniluminal vascular spheroids having outer layers of vascular smooth muscle cells and a contiguous inner layer of endothelial cells lining a central lumen. We showed that while pairs of uniluminal vascular spheroids suspended in culture medium fused to form a larger diameter spheroidal structure, spheroids in collagen hydrogels formed elongated structures. These findings highlight the potential use of uniluminal vascular spheroids as modules to engineer blood vessels. We also demonstrate that uniluminal vascular spheroid fusion conforms to models describing the coalescence of liquid drops. Furthermore, the fusion of uniluminal vascular spheroids in vitro closely resembled the in vivo process by which the descending aorta forms from the fusion of the paired dorsal aortae during embryonic development. Together, the findings indicate that tissue liquidity underlies uniluminal vascular spheroid fusion and that in vivo anastomosis of blood vessels may involve a similar mechanism. Developmental Dynamics 239:398–406, 2010.

24 March 2014 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KGKeyvan Karimi Galougahi
Keyvan Karimi Galougahi
CLChia‐Chi Liu
Chia‐Chi Liu
Carmine GentileCarmine Gentile
Carmine Gentile
CKCindy Kok
Cindy Kok
ANAndrea Nunez
Andrea Nunez
Gemma FigtreeGemma Figtree
Gemma Figtree
Background: Glutathionylation of endothelial nitric oxide synthase ( eNOS ) “uncouples” the enzyme, switching its function from nitric oxide (NO) to O 2 •− generation. We examined whether this reversible redox modification plays a role in angiotensin II (Ang II)‐induced endothelial dysfunction. Methods and Results: Ang II increased eNOS glutathionylation in cultured human umbilical vein endothelial cells (HUVECs), rabbit aorta, and human arteries in vitro. This was associated with decreased NO bioavailability and eNOS activity as well as increased O 2 •− generation. Ang II‐induced decrease in eNOS activity was mediated by glutathionylation, as shown by restoration of function by glutaredoxin‐1. Moreover, Ang II‐induced increase in O 2 •− and decrease in NO were abolished in HUVECs transiently transfected, with mutant eNOS rendered resistant to glutathionylation. Ang II effects were nicotinamide adenine dinucleotide phosphate (NADPH) oxidase dependent because preincubation with gp 91ds‐tat, an inhibitor of NADPH oxidase, abolished the increase in eNOS glutathionylation and loss of eNOS activity. Functional significance of glutathionylation in intact vessels was supported by Ang II‐induced impairment of endothelium‐dependent vasorelaxation that was abolished by the disulfide reducing agent, dithiothreitol. Furthermore, attenuation of Ang II signaling in vivo by administration of an angiotensin converting enzyme (ACE) inhibitor reduced eNOS glutathionylation, increased NO, diminished O 2 •− , improved endothelium‐dependent vasorelaxation and reduced blood pressure. Conclusions: Uncoupling of eNOS by glutathionylation is a key mediator of Ang II‐induced endothelial dysfunction, and its reversal is a mechanism for cardiovascular protection by ACE inhibition. We suggest that Ang II‐induced O 2 •− generation in endothelial cells, although dependent on NADPH oxidase, is amplified by glutathionylation‐dependent eNOS uncoupling.

4 August 2017 in Cells Tissues Organs
Verified
Journal Article
Closed access
GFGemma A. Figtree
Gemma A. Figtree
KBKristen J. Bubb
Kristen J. Bubb
OTOwen Tang
Owen Tang
EKEddy Kizana
Eddy Kizana
Carmine GentileCarmine Gentile
Carmine Gentile
Spheroid cultures are among the most explored cellular biomaterials used in cardiovascular research, due to their improved integration of biochemical and physiological features of the heart in a defined architectural three-dimensional microenvironment when compared to monolayer cultures. To further explore the potential use of spheroid cultures for research, we engineered a novel in vitro model of the heart with vascularized cardiac spheroids (VCSs), by coculturing cardiac myocytes, endothelial cells, and fibroblasts isolated from dissociated rat neonatal hearts (aged 1-3 days) in hanging drop cultures. To evaluate the validity of VCSs in recapitulating pathophysiological processes typical of the in vivo heart, such as cardiac fibrosis, we then treated VCSs with transforming growth factor beta 1 (TGFβ1), a known profibrotic agent. Our mRNA analysis demonstrated that TGFβ1-treated VCSs present elevated levels of expression of connective tissue growth factor, fibronectin, and TGFβ1 when compared to control cultures. We demonstrated a dramatic increase in collagen deposition following TGFβ1 treatment in VCSs in the PicroSirius Red-stained sections. Doxorubicin, a renowned cardiotoxic and profibrotic agent, triggered apoptosis and disrupted vascular networks in VCSs. Taken together, our findings demonstrate that VCSs are a valid model for the study of the mechanisms involved in cardiac fibrosis, with the potential to be used to investigate novel mechanisms and therapeutics for treating and preventing cardiac fibrosis in vitro.

1 June 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RARobin Augustine
Robin Augustine
PDPan Dan
Pan Dan
AHAnwarul Hasan
Anwarul Hasan
IKIsraa Magdi Khalaf
Israa Magdi Khalaf
PPParvathy Prasad
Parvathy Prasad
PMPablo Maureira
Pablo Maureira
Cardiovascular disease is one of the leading causes of mortality worldwide. Cardiac tissue engineering strategies focusing on biomaterial scaffolds incorporating cells and growth factors are emerging as highly promising for cardiac repair and regeneration. The use of stem cells within cardiac microengineered tissue constructs present an inherent ability to differentiate into cell types of the human heart. Stem cells derived from various tissues including bone marrow, dental pulp, adipose tissue and umbilical cord can be used for this purpose. Approaches ranging from stem cell injections, stem cell spheroids, cell encapsulation in a suitable hydrogel, use of prefabricated scaffold and bioprinting technology are at the forefront in the field of cardiac tissue engineering. The stem cell microenvironment plays a key role in the maintenance of stemness and/or differentiation into cardiac specific lineages. This review provides a detailed overview of the recent advances in microengineering of autologous stem cell-based tissue engineering platforms for the repair of damaged cardiac tissue. A particular emphasis is given to the roles played by the extracellular matrix (ECM) in regulating the physiological response of stem cells within cardiac tissue engineering platforms.